Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    miksad
Show Display Options
Rank Status Study
1 Active, not recruiting Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin
2 Active, not recruiting Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Procedure: Radiofrequency Ablation
3 Recruiting Study of Vitamin D in Untreated Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: FOLFOX + bevacizumab;   Dietary Supplement: Vitamin D

Indicates status has not been verified in more than two years